Showing 61-70 of 2652 results for "".
Strategies for Motivating Your Staff
https://modernod.com/topics/business/strategies-for-motivating-your-staff/38975/Simple and effective ways to keep your staff engaged.Why and How to Build up the Myopia Management Aspect of Your Practice
https://modernod.com/topics/myopia/why-and-how-to-build-up-the-myopia-management-aspect-of-your-practice/38142/Six steps to help jump-start your myopia management.Get Medical With Your Contact Lens Prescribing
https://modernod.com/topics/contact-lenses/get-medical-with-your-contact-lens-prescribing/38061/Medically necessary contact lenses can grow your specialty lens practice.Your Mind in Your Business: A Positive Sum Approach to Patient Care
https://modernod.com/topics/business/your-mind-in-your-business-a-positive-sum-approach-to-patient-care/38345/Don’t let too much concern about patient satisfaction keep you from taking proper accountability for patient care.Incorporating Autologous Serum Eye Drops into Your Dry Eye Protocol
https://modernod.com/topics/ocular-surface/incorporating-autologous-serum-eye-drops-into-your-dry-eye-protocol/38191/What you need to know about this advanced treatment option.How to Start on the Right Foot With Your Contact Lens Patients
https://modernod.com/topics/contact-lenses/how-to-start-on-the-right-foot-with-your-contact-lens-patients/37908/You never get a second chance to make a first impression.B+L Receives Approval in Europe for LuxLife IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-receives-approval-in-europe-for-luxlife-iol/37084/Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megAlcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoReduce Your Patient No-Show Rate
https://modernod.com/topics/business/reduce-your-patient-no-show-rate/38556/Boost your clinical efficiency by introducing simple strategies to help patients make their appointments.Expand Your Opportunities for Profitability
https://modernod.com/topics/business/expand-your-opportunities-for-profitability/38671/Consider adding these technologies to your practice and reap the rewards.